NASDAQ: MGRX
Mangoceuticals Inc Stock Ownership - Who owns Mangoceuticals?

Insider buying vs selling

Have Mangoceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eugene M. JohnstonCFO2025-12-095,000$1.20
$5.98kSell
Eugene M. JohnstonCFO2025-12-0510,000$1.13
$11.28kSell
Alex P. HamiltonDirector2025-11-19125,000$1.22
$152.88kSell

1 of 1

MGRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGRX insiders and whales buy or sell their stock.

MGRX Shareholders

What type of owners hold Mangoceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jonathan Arango7.19%1,000,000$1.13MInsider
Jacob D. Cohen4.35%605,000$683.65kInsider
Vanguard Group Inc1.38%192,004$216.96kInstitution
Amanda Elizabeth Hammer1.26%175,000$197.75kInsider
Kenny Myers0.98%136,667$154.43kInsider
Lorraine Pamela Dalessio0.98%136,667$154.43kInsider
Eugene M. Johnston0.89%123,333$139.37kInsider
Geode Capital Management LLC0.63%87,974$99.41kInstitution
Antonios Isaac0.43%60,000$67.80kInsider
Ackerman Capital Advisors LLC0.25%34,500$38.99kInstitution

1 of 2

MGRX vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGRX2.69%16.11%Net SellingNet Selling
VSEE2.63%25.18%
ZCMD0.18%0.00%
HCTI0.33%99.67%
BFRG3.61%21.65%Net Selling

Mangoceuticals Stock Ownership FAQ

Who owns Mangoceuticals?

Mangoceuticals (NASDAQ: MGRX) is owned by 2.69% institutional shareholders, 16.11% Mangoceuticals insiders, and 81.20% retail investors. Jonathan Arango is the largest individual Mangoceuticals shareholder, owning 1.00M shares representing 7.19% of the company. Jonathan Arango's Mangoceuticals shares are currently valued at $1.13M.

If you're new to stock investing, here's how to buy Mangoceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.